SECsense Logo

Monopar Therapeutics Inc. 8-K Report: Key Updates & Insights for Investors

$MNPR
Form 8-K
Filed on: 2025-02-24
Source
Monopar Therapeutics Inc. 8-K Report: Key Updates & Insights for Investors

From the provided XML section of the financial report, here are the key pieces of information extracted:

  1. Entity Information:
  • Company Name: Monopar Therapeutics Inc.
  • CIK (Central Index Key): 0001645469
  • IRS Employer Identification Number: 32-0463781
  • Address: 1000 Skokie Blvd., Suite 350, Wilmette, IL 60091
  • Phone Number: 847-388-0349
  • Stock Ticker: MNPR
  • Exchange: NASDAQ
  1. Filing Information:
  • Form Type: 8-K (This form is typically used for current reports to disclose important events that may affect the company)
  • Filing Date: February 19, 2025
  1. Stock Information:
  • Common Stock Par Value: $0.001
  1. Reporting Period:
  • Start Date: February 19, 2025
  • End Date: February 19, 2025

Insights:

  • The filing is a current report (8-K) which indicates that the company is disclosing information that may be significant for investors or stakeholders.
  • The report covers a specific date, suggesting that it may involve an event or development occurring on that day.
  • The inclusion of the common stock details indicates that this report could relate to stockholder information or corporate governance matters.

This information is critical for stakeholders to understand the company's current status and any significant events that may affect its operations or stock performance.